FDA elevates Vitruvia’s thyroid tablet recall to class I, its most serious risk level The U. S. Food and Drug Administration has upgraded a recall of Vitruvias Therapeutics’ 30mg thyroid tablets to a class I designation. This marks the agency’s highest-risk category. ..
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan